Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
AI-based health coaching aids blood pressure management
Jun 12, 2024
Improvements in both systolic and diastolic blood pressure were seen at 12 weeks and were even greater at 24 weeks.
Southern living can take a toll on health, rankings suggest
By
John O'Connor
Sep 16, 2020
The South rightfully can be proud of its reputation for friendliness and top-notch cuisine. But it’s also where people requiring home health services likely are to be found in disproportionately high...
Nighttime hot spring bathing may decrease prevalence of HTN in older adults
Jan 05, 2023
An inverse relationship was seen between habitual nighttime hot spring bathing and a history of hypertension.
Salt substitute can reduce incidence of hypertension among seniors
Feb 12, 2024
No increase was seen in the incidence of hypotension episodes with replacement of salt by a potassium-enriched substitute.
Sedentary behavior reduction intervention cuts sitting time, BP in seniors
Mar 29, 2024
The intervention reduced sitting time at three and six months and yielded a reduction in systolic blood pressure at six months.
AHA: Fresh produce prescription improves glycemic control
Nov 14, 2023
The findings were seen among low-income individuals with diabetes and poor glycemic control.
Hypertension while lying down tied to worse cardiovascular disease outcomes
Sep 13, 2023
Findings seen regardless of whether hypertension persists in seated position
For self-measured BP, smartphone app no better than standard device
Aug 15, 2022
Self-measured blood pressure paired with a connected smartphone app is not superior to standard self-measured blood pressure for blood pressure reduction and patient satisfaction.
Ultra-low-dose combo cuts systolic BP in hypertension
Aug 30, 2021
The reduction in systolic blood pressure was greater at week 12 with the fixed-dose quadruple quarter-dose combo versus standard-dose monotherapy.